Testing effectiveness (Phase 2)Active Not RecruitingNCT03838159What this trial is testingNADIM II: Neo-Adjuvant ImmunotherapyWho this might be right forNon Small Cell Lung Cancer Fundación GECP 90
Testing effectiveness (Phase 2)Study completedNCT01636934What this trial is testingMinocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation TherapyWho this might be right forLung Cancer M.D. Anderson Cancer Center 51
Large-scale testing (Phase 3)UnknownNCT00055965What this trial is testingHospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or CarboplatinWho this might be right forLung Cancer The Christie NHS Foundation Trust 400
Not applicableStudy completedNCT01928836What this trial is testingRisk Stratification of Patients Using the Lung Cancer Biomarker Panel in ChinaWho this might be right forLung Neoplasms Bai Chunxue 764
Not applicableStudy completedNCT01741636What this trial is testingSurvivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung CancerWho this might be right forStage I Colon CancerStage I Rectal CancerStage IA Non-small Cell Lung Cancer+17 more City of Hope Medical Center 30
Early research (Phase 1)Ended earlyNCT03927573What this trial is testingStudy With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA MarkerWho this might be right forNon-small Cell Lung CancerProstate CancerRenal Cancer+1 more AvenCell Europe GmbH 23
Not applicableUnknownNCT06564870What this trial is testingEfficacy and Safety Study of DURVALUMAB Maintenance in Patients With Stage III Non-Small Cell Lung CancerWho this might be right forBronchial Cancer University Hospital, Brest 200
Early research (Phase 1)Ended earlyNCT01891669What this trial is testingPF-06263507 In Patients With Advanced Solid TumorsWho this might be right forNeoplasmsCarcinoma, Non Small Cell LungBreast Neoplasms+1 more Pfizer 26
Large-scale testing (Phase 3)Study completedNCT00003869What this trial is testingCarboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung CancerWho this might be right forStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer National Cancer Institute (NCI) 186
Large-scale testing (Phase 3)Study completedNCT01652469What this trial is testingTesting of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.Who this might be right forCarcinoma, Non-Small-Cell Lung ETOP IBCSG Partners Foundation 81
Testing effectiveness (Phase 2)Study completedNCT03535740What this trial is testingBrigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or CeritinibWho this might be right forALK-positive Advanced NSCLC Ariad Pharmaceuticals 103
Early research (Phase 1)Active Not RecruitingNCT05068102What this trial is testingTest How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking EzabenlimabWho this might be right forCarcinoma, Squamous Cell of Head and Neck (HNSCC)MelanomaNon-small Cell Lung Cancer (NSCLC) Boehringer Ingelheim 14
Testing effectiveness (Phase 2)Study completedNCT00002972What this trial is testingPaclitaxel in Treating Patients With Lung CancerWho this might be right forLung Cancer European Organisation for Research and Treatment of Cancer - EORTC 25
Testing effectiveness (Phase 2)Study completedNCT02417701What this trial is testingSapanisertib in Treating Patients With Stage IV or Recurrent Lung CancerWho this might be right forRecurrent Lung Squamous Cell CarcinomaStage IV Lung Squamous Cell Carcinoma AJCC v7 National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT01725165What this trial is testingSurgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung CancerWho this might be right forRecurrent Lung Non-Small Cell CarcinomaStage IV Non-Small Cell Lung Cancer AJCC v7 M.D. Anderson Cancer Center 85
Large-scale testing (Phase 3)Active Not RecruitingNCT06396065What this trial is testingPhase III Study of AK112 for NSCLC PatientsWho this might be right forNon-Squamous Non-small Cell Lung Cancer Summit Therapeutics 420
Testing effectiveness (Phase 2)Looking for participantsNCT06363734What this trial is testingOsimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II TrialWho this might be right forNon-small Cell Lung CancerEGFR Activating MutationCell Cycle Deregulation+1 more Tianjin Medical University Cancer Institute and Hospital 32
Testing effectiveness (Phase 2)Study completedNCT00092001What this trial is testingStudy Of SU011248 In Patients With Metastatic Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Pfizer 111
Testing effectiveness (Phase 2)Study completedNCT00368992What this trial is testingS0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung CancerWho this might be right forAdenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+5 more National Cancer Institute (NCI) 110
Large-scale testing (Phase 3)Study completedNCT00982111What this trial is testingFirst-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-CisplatinWho this might be right forNon Small Cell Lung Cancer Eli Lilly and Company 633